Dcpl Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-12-2024
- Paid Up Capital ₹ 0.20 M
as on 06-12-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 06-12-2024
- Revenue 74.74%
(FY 2020)
- Profit -3509.99%
(FY 2020)
- Ebitda -503.51%
(FY 2020)
- Net Worth -83.84%
(FY 2020)
- Total Assets 5.17%
(FY 2020)
About Dcpl Life Science
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹2.00 M.
Sharad Doshi and Harsh Doshi serve as directors at the Company.
- CIN/LLPIN
U24233MP2005PTC017860
- Company No.
017860
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- LocationIndore, Madhya Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dcpl Life Science Private Limited offer?
Dcpl Life Science Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Common Disease Medicines, Skin Lightening Drugs, Fresh Flowers, Plants & Trees, Flowering Plant, Tea & Coffee, Herbal Tea, Herbal Supplements, Herbal Slimming Capsule Tablet.
Who are the key members and board of directors at Dcpl Life Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Doshi  | Director | 10-Aug-2005 | Current |
| Harsh Doshi | Director | 10-Aug-2005 | Current |
Financial Performance and Corporate Structure Insights of Dcpl Life Science.
Dcpl Life Science Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 74.74% increase. The company also saw a substantial fall in profitability, with a 3509.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 83.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dcpl Life Science?
In 2020, Dcpl Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Doshi Consultants Private LimitedActive 28 years 4 monthsSharad Doshi and Harsh Doshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 20 Jan 2011 | ₹2.00 M | Open |
How Many Employees Work at Dcpl Life Science?
Unlock and access historical data on people associated with Dcpl Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dcpl Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dcpl Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
